Nestle Peptamen 1 Cal Liquid, Unflavored, 8.45 oz, 24 Count


$255.65 $332.35

Disponibilité:
En stock
  • Livraison estimée:Jan 04 - Jan 11

  • Expédition et retours gratuits: On all orders

Paiement sécurisé garanti

  • Free Shipping & Returns or all orders over
  • Secure Payment We ensure secure payment
  • Money Back Guarantee Any back within 30 days

Product Description

Nestlé Peptamen 1.0 Cal is a nutritionally complete, peptide-based formula designed for adults with impaired digestion or absorption of nutrients. It comes in 8.45-ounce cartons, with 24 cartons per case, and is unflavored. The formula is designed for oral or tube feeding and is appropriate for those with conditions like short bowel syndrome, inflammatory bowel disease, or malabsorption syndromes. It is also gluten-free and suitable for lactose intolerance.

Product Highlights

  • NUTRITIONALLY COMPLETE PEPTIDE FORMULA: Peptamen formula is for those with difficulty digesting or absorbing nutrients from solids or liquids; contains a balanced peptide profile to promote GI absorption and tolerance
  • FOR SHORT OR LONG-TERM TUBE FEEDING: Nutritionally complete & with high calories in a smaller volume, Peptamen formula addresses the nutritional needs of those with GI dysfunction & may help with gastric emptying.
  • WELL TOLERATED: Made to meet nutritional needs & support tolerance in adults with GI dysfunction. Peptamen formulas are also available in vanilla flavor for oral feeding.
  • DIET APPROPRIATENESS: This product is gluten-free & suitable for lactose intolerance. Not appropriate for individuals with cows' milk protein allergy. This product is intended for use under medical supervision.
  • Nestle Health Science's portfolio of nutrition solutions targets a number of health areas, such as pediatric and acute care, surgery, weight management, healthy aging and gastrointestinal health.
  • During the summer months products may arrive warm but -- stores and ships products in accordance with manufacturers' recommendations, when provided.

Soumettez vos commentaires

Your email address will not be published. Required fields are marked *

1 2 3 4 5